Study of proliferating cell nuclear antigen and p185 in non-small cell lung cancer;Estudio de la expresión del antígeno nuclear de proliferación celular y p185 en el carcinoma no microcítico de pulmón

Archivos de Bronconeumologia

Volumn 32, Issue 4, 1996, Pages 165-169

  Alemany Monraval, P ^a,b   Martorell Cebollada, M ^a   Salvador Villalba, I ^a   Martinez Leandro E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b NONE   (Spain)

Author keywords

Non small cell lung cancer; Proliferating cell nuclear antigen p185

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADENOCARCINOMA; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MORTALITY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TIME;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ERBB-2; TIME FACTORS;

EID: 0030116470     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30781-x     Document Type: Article

References (31)

1. Agudo A, Gonzalez CA, Torrent M. Exposición ambiental al humo del tabaco y cancer de pulmón. Med Clin (Barc) 1989; 93: 387-393.
2. Kern JA, Filderman AE. Oncogenes and growth factors in human lung cancer. Clin Chest Medic 1993; 14: 31-41.
3. Celis JE, Celis A. Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci 1985; 82: 3.262-3.266.
4. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation: its distribution in synchronized cells. J Exp Med 1981; 154: 1.899-1.909.
5. Hall PA, Levison DA, Woods AL et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffion sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285-294.
6. Fontanini G, Macchiarini P, Pepe S et al. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 1992; 70: 1.520-1.527.
7. Carey F, Fabbroni G, Lamb D. Expression of proliferating cell nuclear antigen in lung cancer: a systematic study and correlation with DNA ploidy. Histopathology 1992; 20: 499-503.
8. Theunissen PH, Leers MP, Bollen EC. Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 1992; 20: 251-255.
9. Coussens L, Yang-Feng T, Liao Y-C et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985; 230: 1.132-1.139.
10. Schechter AL, Hung MCH, Vaidyanathan L et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985; 229: 976-978.
11. Slamon DJ, Godolphin W, Jones LA et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989; 244: 707-712.
12. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
13. Berger MS, Locher GW, Saurer S et al. Correlation of c-erb-B-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48: 1.238-1.243.
14. Weiner DB, Nordberg J, Robinson R et al. Expression of the neu gene-encoded protein (p185 neu) in human non-small cell carcinomas of the lung. Cancer Res 1990; 50: 421-425.
15. Mountain C. A new international staging system for lung cancer. Chest 1986; 89 (Supl): 225-228.
16. a ed.). Am J Clin Pathol 1982; 77: 123-126.
17. Hsu SM, Raine L; Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577-580.
18. Norusis MJ. SPSS/PC+ Statics 4.0. SPSS. Inc. Michigan, 1986.
19. Norusis MJ. SPSS/PC+ Advanced statics 4.0. SPSS. Inc. Michigan, 1986.
20. Boring CC, Squires TS, Tong T. Cancer statistics 1992. CA 1992; 42: 19-38.
21. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990; 43: 184-192.
22. Waseen NK, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121-129.
23. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 1987; 168: 475-486.
24. Ogata K, Ogata Y, Takasaki Y, Tan EM. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol 1987; 139: 2.942-2.945.
25. Wolf H, Dittrich KL. Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 1992; 40: 1.269-1.273.
26. Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 1993; 53: 5.000-5.003.
27. Press MF, Hung G, Godolphin W, Slamon D. Sensivity of HER-2/neu antibodies in archival tissue samples: potencial source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994; 54: 2.771-2.777.
28. Shi D, He G, Cao SH et al. Overexpression of the c-erbB-2/neu encoded p 185 protein in primary lung cancer. Mol Carcinog 1992; 5:213-218.
29. Kern JA, Schwartz DA, Nordberg JE et al. p185 neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990; 50: 5.184-5.191.
30. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 1991; 27: 1.372-1.375.
31. Kern JA, Robinson RA, Gazdar A, Tomey L, Weiner B. Mechanisms of p185 HER2 expression in human non-small cell lung cancer cell lines. Am J Respir Cell Mol Biol 1992; 6: 359-363.